| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.8M | +0.8% |
| Cost of Revenue | $3.3M | -21.1% |
| Gross Profit | $5.6M | +20.4% |
| R&D Expense | $35.3M | -6.8% |
| SG&A Expense | $32.4M | -12.4% |
| Operating Income | -$77.2M | +4.1% |
| Pre-tax Income | -$143.9M | -73.9% |
| Net Income | -$143.9M | -73.9% |
| EPS (Basic) | -$0.75 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $178.0M | +330.9% |
| Accounts Receivable | $1.4M | -14.0% |
| Inventory | $1.7M | -18.9% |
| Current Assets | $185.0M | +293.3% |
| Total Assets | $199.9M | +236.7% |
| Current Liabilities | $30.1M | +168.0% |
| Long-term Debt | $30.1M | -52.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.6M | +29.7% |
| Capital Expenditures | $2.1M | +261.2% |
| Investing Cash Flow | -$3.1M | -398.6% |
| Financing Cash Flow | $182.4M | +90.8% |
| Free Cash Flow | -$44.7M | +26.9% |
| -25.0% |
| EPS (Diluted) | -$0.75 | -25.0% |
| Total Liabilities |
| $137.2M |
| +63.7% |
| Stockholders' Equity | $62.6M | +355.9% |